News search

E.g., 13/08/2020
E.g., 13/08/2020
Research
29 May 2020

The researcher Alejandro Sánchez Alvarado is one of the greatest experts in the study of the mechanisms involved, cellular and biological, in regeneration in the planaria model

Research
3 Dec 2019

Scientists at the CNIC and CSIC have identified a function of a protease that could be the future target of drugs to treat inflammatory bowel disease

Research
31 Oct 2019

Dr. Miguel Torres, of the Centro Nacional de Investigaciones Cardiovasculares (CNIC), leads a new project that will receive €8 million in funding over 5 years, €1,380,000 of which will be directly managed at the CNIC

Research
5 Sep 2019

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease

Research
3 Apr 2018

The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

Research
3 Apr 2018

ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián

About the CNIC
7 Mar 2017

The State Research Agency nominates José María Ordovás as member of its Scientific and Technical Committee


About the CNIC
6 Feb 2017

The Spanish Society of Cardiology (SEC) and The Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have created an ambitious joint plan of postgraduate training for cardiologists in order to promote good quality research in the cardiovascular field

Research
21 Dec 2016

ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián


Research
2 Nov 2016

La información permitirá abrir nuevas líneas de investigación para el desarrollo de nuevas terapias dirigidas a corregir estos defectos que caracterizan a la progeria